NICE rejects groundbreaking Alzheimer’s drugs: What it means for the UK
In a move that has triggered disappointment across the [...]
Economics in health: Improving productivity, addressing unmet needs and prevention in the NHS
How the NHS can optimise health outcomes in a time [...]
A new era in Alzheimer’s diagnosis: What the FDA’s first approved blood test means for the UK
On 16 May 2025, the U.S. Food and Drug [...]
European Health Data Space: The EU’s Digital Health Framework
The European Health Data Space (EHDS) is a major [...]
CF recognised as a top Middle East consulting firm by Consultancy-me
We are thrilled to announce that CF has been [...]
What does the 2024 Budget mean for the NHS and Life Sciences?
Today sees the release of the 2024 Budget – [...]
Maximising healthcare outcomes through NHS-industry partnerships
NHS-industry partnerships aim to develop and implement projects that [...]
Review into the operational effectiveness of the CQC
In May 2024, Dr Penny Dash conducted a review [...]
The greatest challenges and opportunities in dementia
Dementia is one of the UK's most pressing health [...]
Partnering for progress: a data-driven analysis of NHS-industry partnerships
Early evidence links NHS-industry partnerships with improved prescribing practices [...]
